Levy Richard S

Average Profitability
321.79%
Insider Buys Quantity
4
Insider Buys Sum
$234,463.27
Insider Sells Quantity
37
Insider Sells Sum
$64.49M

Insider Activity of Levy Richard S

According to the SEC Form 4 filings, Levy Richard S, being in a position of

  1. director at Madrigal Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 16000 shares for $4.34M,
    over all time since 2017-08-21, has bought 9100 shares for $145,803, and sold 38489 shares for $10.93M.

The largest purchase of all time was on 2020-03-20 and amounted to 2000 shares of Kodiak Sciences Inc. for $88,660.

The largest sale of all time was on 2014-02-13 and amounted to 191309 shares of Incyte Corporation for $12.7M.

Biography of Levy Richard S

No biography is available at this moment.

2024-11-01SaleMadrigal Pharmaceuticals, Inc.
MDGL
director
5,000
0.0217%
$300.94$1.5M+3.67%
2024-04-01SaleMadrigal Pharmaceuticals, Inc.
MDGL
director
11,000
0.0557%
$257.49$2.83M-7.54%
2023-01-17SaleMadrigal Pharmaceuticals, Inc.
MDGL
director
22,489
0.1227%
$293.15$6.59M-21.53%
2020-03-20PurchaseKodiak Sciences Inc.
KOD
director
2,000
0.0044%
$44.33$88,660+40.96%
2017-08-23PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
2,000
0.0154%
$16.12$32,236+580.11%
2017-08-22PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
3,550
0.0287%
$16.12$57,209+613.24%
2017-08-21PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
3,550
0.0283%
$15.88$56,358+614.47%
2016-01-06SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
7,874
0.0025%
$60.09$473,149-20.19%
2015-12-07SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
7,874
0.0024%
$62.25$490,157-24.24%
2015-11-06SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
7,872
0.0028%
$67.42$530,691-18.61%
2015-10-06SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
7,874
0.0026%
$70.31$553,582-27.43%
2015-09-11SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
8,602
0.0047%
$130.00$1.12M-37.51%
2015-09-08SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
7,874
0.0025%
$68.61$540,235-31.76%
2015-08-06SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
7,872
0.0027%
$65.14$512,743-18.46%
2015-07-15SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
140,434
0.046%
$68.89$9.68M-26.04%
2015-07-06SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
7,874
0.0025%
$62.66$493,385-10.32%
2015-06-19SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
40,000
0.0131%
$62.96$2.52M-3.74%
2015-06-08SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
7,874
0.0026%
$62.95$495,668-2.61%
2015-05-06SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
14,824
0.0049%
$58.88$872,763+5.34%
2015-04-06SaleIncyte Corporation
INCY
EVP, Chief Drug Dev Officer
50,000
0.0169%
$53.55$2.68M+20%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.